These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20045984)

  • 21. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes.
    Haumont M; Magdalou J; Lafaurie C; Ziegler JM; Siest G; Colin JN
    Arch Biochem Biophys; 1990 Sep; 281(2):264-70. PubMed ID: 2118332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
    Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
    Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation.
    Uchaipichat V; Raungrut P; Chau N; Janchawee B; Evans AM; Miners JO
    Drug Metab Dispos; 2011 Aug; 39(8):1324-8. PubMed ID: 21551257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory Effect of Sauchinone on UDP-Glucuronosyltransferase (UGT) 2B7 Activity.
    You BH; Gong EC; Choi YH
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29425147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herbal medicine and false-positive results on lymphocyte transformation test.
    Mantani N; Sakai S; Kogure T; Goto H; Shibahara N; Kita T; Shimada Y; Terasawa K
    Yakugaku Zasshi; 2002 Jun; 122(6):399-402. PubMed ID: 12087777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones.
    Herber R; Magdalou J; Haumont M; Bidault R; van Es H; Siest G
    Biochim Biophys Acta; 1992 Jun; 1139(1-2):20-4. PubMed ID: 1610916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory Effects of Baicalein Derived from Japanese Traditional Herbal Medicine on SN-38 Glucuronidation.
    Satoh T; Igarashi A; Tanno M; Yamada K; Takahashi-Suzuki N; Watanabe K
    J Pharm Pharm Sci; 2018; 21(1):195-206. PubMed ID: 29891024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.
    King C; Tang W; Ngui J; Tephly T; Braun M
    Toxicol Sci; 2001 May; 61(1):49-53. PubMed ID: 11294973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
    Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
    J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
    Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction.
    Rowland A; Elliot DJ; Williams JA; Mackenzie PI; Dickinson RG; Miners JO
    Drug Metab Dispos; 2006 Jun; 34(6):1055-62. PubMed ID: 16565174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms.
    Isobe T; Ohkawara S; Tanaka-Kagawa T; Jinno H; Hanioka N
    Arch Toxicol; 2017 Nov; 91(11):3543-3550. PubMed ID: 28500425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of human UDP-glucuronosyltransferase isoforms responsible for the glucuronidation of glycyrrhetinic acid.
    Lu Y; Zhu J; Chen X; Li N; Fu F; He J; Wang G; Zhang L; Zheng Y; Qiu Z; Yu X; Han D; Wu L
    Drug Metab Pharmacokinet; 2009; 24(6):523-8. PubMed ID: 20045987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucuronidation of 3'-azido-3'-deoxythymidine catalyzed by human liver UDP-glucuronosyltransferase. Significance of nucleoside hydrophobicity and inhibition by xenobiotics.
    Resetar A; Minick D; Spector T
    Biochem Pharmacol; 1991 Jul; 42(3):559-68. PubMed ID: 1907149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver.
    Mano Y; Usui T; Kamimura H
    Eur J Clin Pharmacol; 2007 Mar; 63(3):289-96. PubMed ID: 17245571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
    Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
    Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Udp-glucuronosyltransferase 2b7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomes.
    Bauman JN; Goosen TC; Tugnait M; Peterkin V; Hurst SI; Menning LC; Milad M; Court MH; Williams JA
    Drug Metab Dispos; 2005 Sep; 33(9):1349-54. PubMed ID: 15980101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro inhibitory effects of Kampo medicines on metabolic reactions catalyzed by human liver microsomes.
    Takahashi K; Uejima E; Morisaki T; Takahashi K; Kurokawa N; Azuma J
    J Clin Pharm Ther; 2003 Aug; 28(4):319-27. PubMed ID: 12911685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.